CN105770404A - Traditional Chinese medicine for treating heart disease - Google Patents
Traditional Chinese medicine for treating heart disease Download PDFInfo
- Publication number
- CN105770404A CN105770404A CN201610350529.5A CN201610350529A CN105770404A CN 105770404 A CN105770404 A CN 105770404A CN 201610350529 A CN201610350529 A CN 201610350529A CN 105770404 A CN105770404 A CN 105770404A
- Authority
- CN
- China
- Prior art keywords
- radix
- chinese medicine
- traditional chinese
- rhizoma
- heart disease
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/232—Angelica
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
- A61K36/066—Clavicipitaceae
- A61K36/068—Cordyceps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/07—Basidiomycota, e.g. Cryptococcus
- A61K36/076—Poria
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/233—Bupleurum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
- A61K36/236—Ligusticum (licorice-root)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/25—Araliaceae (Ginseng family), e.g. ivy, aralia, schefflera or tetrapanax
- A61K36/258—Panax (ginseng)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/535—Perilla (beefsteak plant)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/537—Salvia (sage)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/57—Magnoliaceae (Magnolia family)
- A61K36/575—Magnolia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/66—Papaveraceae (Poppy family), e.g. bloodroot
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/75—Rutaceae (Rue family)
- A61K36/752—Citrus, e.g. lime, orange or lemon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/79—Schisandraceae (Schisandra family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/888—Araceae (Arum family), e.g. caladium, calla lily or skunk cabbage
- A61K36/8888—Pinellia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8968—Ophiopogon (Lilyturf)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
Abstract
The invention relates to a traditional Chinese medicine for treating heart disease. The traditional Chinese medicine is prepared from the following traditional Chinese medicinal materials by weight: 6-9g of angelica sinensis, 6-9g of ligusticum wallichii, 7-10g of salviae miltiorrhizae, 7-10g of poria cocos, 6-15g of schisandra chinesis(turcz) baill, 7-10g of mangnolia officinalis, 6-9g of dry longan, 6-9g of pinellia ternate, 6-9g of perillaseeds, 7-9g of aster, 6-9g of American ginseng, 7-10g of radix ophiopogonis, 6-8g of rhizoma corydalis, 1-3g of saffron crocus, 6-9g of pericarpium citri reticulatae, 6-9g of testiset penis phocae, 1-3g of cordyceps sinensis, 8-10g of radix bupleuri and 8-10g of platycodon grandiflorum. The traditional Chinese medicine is a traditional Chinese medicine composition which is high in recovery rate, significant in curative effect, short in treatment course and low in treatment cost.
Description
Technical field
The present invention relates to one and treat cardiopathic medicine, especially one treats the cardiopathic oral Chinese herbal medicine of deficiency myocardial blood supply class.
Background technology
It is known that, the blood circulation of human body is by the sanguimotor neuro humor organizational composition of heart, blood vessel and adjustment, and blood circulation diseases is also referred to as cardiovascular diseases, including the disease of above-mentioned all histoorgans, internal disease belongs to commonly encountered diseases, wherein common with heart disease.Heart disease is most commonly that coronary heart disease, and myocardial ischemia (deficiency myocardial blood supply) is the one of coronary heart disease, be the formidable enemy of health of people.At present, the medicine for the treatment of myocardial ischemia has Radix Salviae Miltiorrhizae Tabellae (to be made up of Radix Salviae Miltiorrhizae, Radix Notoginseng, Borneolum Syntheticum etc., have coronary artery dilator, increase coronary flow, reduce the effect such as blood viscosity and blood clotting.Thoracic obstruction patient suitable in Blood stasis), FUFANG DANSHEN PIAN or ball (have coronary artery dilator, increase coronary flow, suppress platelet aggregation, protect ischemic myocardium and improve the effects such as microcirculation.Suitable in angina pectoris acute attack, be also used for prevention angina pectoris attacks), Heart pill of Musk (is made up of Moschus, styracin, Calculus Bovis, Cortex Cinnamomi, Venenum Bufonis, Borneolum Syntheticum, Radix Ginseng extract etc..There is the rising suppressing serum total cholesterol and low-density lipoprotein cholesterol level, alleviate vascular endothelial cell injury, suppress its intimal hyperplasia, improve the effects such as myocardial ischemia, onset is rapid, suitable in angina pectoris acute attack, or be used for preventing or alleviating angina pectoris attacks), DIAOXINXUE KANG (forms by the steroidal Total saponin extracted in peculiar medicinal plants is refining, has the increase effect such as coronary flow and myocardial alimentary blood flow, reduction blood fat, blood viscosity and platelet aggregation rate.Especially being applicable to uncomfortable in chest is main patient or qi stagnation and blood stasis type thoracic obstruction patient.Bradycardia person is cautious use of), the heart can relax and (be made up of Radix Salviae Miltiorrhizae, Radix Puerariae, Radix Notoginseng, the Radix Aucklandiae, Fructus Crataegi etc..Have and improve myocardial ischemia and microcirculation, enhancing myocardial contraction, improve the effect such as Ventricular diastolic function.Suitable in qi stagnation and blood stasis type thoracic obstruction patient), arteria coronaria rather (is made up of Radix Salviae Miltiorrhizae, Radix Angelicae Sinensis, Flos Carthami, Sanguis Draxonis, Caulis Spatholobi, Rhizoma Corydalis, Semen Persicae, Radix Polygoni Multiflori, Rhizoma Polygonati etc..There is increase coronary flow, improve myocardial ischemia, suppress platelet aggregation, reduce the effects such as blood viscosity.Suitable in qi stagnation and blood stasis type thoracic obstruction patient), Tongxinluo (is made up of Radix Ginseng, Hirudo, Scorpio, Eupolyphaga Seu Steleophaga, Scolopendra, Periostracum Cicadae, Radix Paeoniae Rubra, Borneolum Syntheticum etc..Have increase coronary flow, improve myocardial ischemia, regulate blood fat, reduce blood viscosity, suppress platelet aggregation, and have effects such as improving blood vessel inner skin cell function), Nuodikang is (for Tibetan medicine (Radix Rhodiolae).Have and improve myocardial ischemia, regulate blood fat, reduce blood viscosity, suppress the effects such as platelet aggregation.Suitable in qi stagnation and blood stasis type thoracic obstruction patient) and gingko leaf preparation (for the natural active matter extracted Folium Ginkgo, can improve myocardial ischemia, reduce blood viscosity and protection blood vessel inner skin cell function etc..Suitable in qi stagnation and blood stasis type thoracic obstruction patient) etc..The medicine of above-mentioned treatment myocardial ischemia, all can only prevent generation, relief of symptoms, it is impossible to effectively fundamentally treat heart disease.Therefore, study a kind of Chinese medicine that can cure heart disease particularly coronary heart disease Myocardial blood supply insufficiency, be presently required to solve the technical problem that.
Summary of the invention
The technical problem to be solved is to provide a kind of Chinese medicine that can cure heart disease particularly coronary heart disease.
This invention address that the technical scheme of its technical problem is:
One treats cardiopathic Chinese medicine, and it contains the Chinese crude drug of following component, and the composition of each component is all in units of weight: Radix Angelicae Sinensis 6~9g, Rhizoma Chuanxiong 6~9g, Radix Salviae Miltiorrhizae 7~10g, Poria 7~10g, FRUCTUS SCHISANDRAE from Liaoning of China 6~15g, Cortex Magnoliae Officinalis 7~10g, unit meat 6~9g, the Rhizoma Pinelliae 6~9g, Fructus Perillae 6~9g, Radix Asteris 7~9g, Radix Panacis Quinquefolii 6~9g, Radix Ophiopogonis 7~10g, Rhizoma Corydalis 6~8g, Stigma Croci 1~3g, Pericarpium Citri Reticulatae 6~9g, Testis et penis callorhini 6~9g, Cordyceps 1~3g, Radix Bupleuri 8~10, Radix Platycodonis 8~10.
As a preferred embodiment of the present invention, the content of each component is: Radix Angelicae Sinensis 7~8g, Rhizoma Chuanxiong 7~8g, Radix Salviae Miltiorrhizae 8~9g, Poria 8~9g, FRUCTUS SCHISANDRAE from Liaoning of China 8~12g, Cortex Magnoliae Officinalis 8~9g, unit meat 7~8g, the Rhizoma Pinelliae 7~8g, Fructus Perillae 7~8g, Radix Asteris 7~8g, Radix Panacis Quinquefolii 7~8g, Radix Ophiopogonis 8~9g, Rhizoma Corydalis 7g, Stigma Croci 2g, Pericarpium Citri Reticulatae 7~8g, Testis et penis callorhini 7~8g, Cordyceps 2g, Radix Bupleuri 9, Radix Platycodonis 9.
As a preferred embodiment of the present invention, the content of each component is: Radix Angelicae Sinensis 8g, Rhizoma Chuanxiong 8g, Radix Salviae Miltiorrhizae 9g, Poria 9g, FRUCTUS SCHISANDRAE from Liaoning of China 10g, Cortex Magnoliae Officinalis 9g, unit meat 8g, Rhizoma Pinelliae 8g, Fructus Perillae 8g, Radix Asteris 8g, Radix Panacis Quinquefolii 8g, Radix Ophiopogonis 9g, Rhizoma Corydalis 7g, Stigma Croci 2g, Pericarpium Citri Reticulatae 8g, Testis et penis callorhini 8g, Cordyceps 2g, Radix Bupleuri 9, Radix Platycodonis 9.
The each component of the present invention is on pharmacy or market the finished product Chinese crude drug buied, and its instructions of taking is the Chinese medicine instructions of taking that is decocted in water for oral dose generally adopted.The each component Chinese medicine of the present invention being about to prepare puts into marmite or other decocting container in the lump, places appropriate water low baking temperature and decocts 15 20 minutes, takes concoction oral, and every day is sooner or later respectively once.Can also using conventional methods, a dose of medicine adds water fried after having decocted an extracting juice, takes at twice, sooner or later respectively once after twice medicine juice mixing.Also said components can be ground to form by the fine powder that mesh is 0.4 screen cloth, and by above-mentioned fine powder 500g, starch 50g and distilled water 250g, mix homogeneously, make the pill of 0.14g mass with pellet processing machine.
Present invention observed result after the Clinical practice to 290 cardiacs of more than 45 years old is as follows:
1. 284 people have curative effect in various degree, effective percentage more than 98%;
2. 275 people cure, cure rate 95%;
3. 6 people are because suffering from diabetic complications without obvious curative effects;
4. 9 people are also had to have obvious curative effects except curing except 275 people.
The pharmacological effect of the present invention is: blood circulation promoting and blood stasis dispelling, hemopoietic of invigorating blood circulation, hemopoietic reinforcing the heart, and tissue regeneration promoting blood removes stagnant blood, ventilation of reducing phlegm, and dredges cardiac size blood vessel, and promoting the circulation of QI to relieve pain, normal circulation of qi and blood is then healed.
The present invention compared with prior art has the advantage that
1. can fundamentally treating heart disease, effective percentage is up to more than 98%, and cure rate is up to more than 95%;
2. have no side effect, can effectively dredge cardiac size blood vessel, ventilation of reducing phlegm, reach normal circulation of qi and blood then heal effect;
3. treating short treating period, expense is low, it is adaptable to multiple cardiopathic treatment, particularly coronary heart disease, myocardial ischemia;
Below by several model cases illustrate the present invention therapeutic effect:
Case one, field so-and-so, man, 53 years old, Cixian, hebei Province ancient city people from town, suffer from coronary heart disease.Three recoveries from illness course for the treatment of, did not recur after recovery from illness.
Case two, Zhao so-and-so, female, 60 years old, high mountain, Cixian, hebei Province be grown up, suffer from coronary heart disease.Four recoveries from illness course for the treatment of, did not recur after recovery from illness.
Case three, Lee so-and-so, man, 64 years old, Lin Tan people from town, Cixian, hebei Province, suffer from coronary heart disease.Three recoveries from illness course for the treatment of, did not recur after recovery from illness.
Case four, military so-and-so, female, 49 years old, Congtai District, Handan City, suffer from coronary heart disease.Two recoveries from illness course for the treatment of, did not recur after recovery from illness.
Case five, Hao so-and-so, female, 75 years old, people from Hanshan District, Handan City, suffer from coronary heart disease.Five recoveries from illness course for the treatment of, did not recur after recovery from illness.
Detailed description of the invention enumerates 10 specific embodiments of the present invention below by the mode of list, and the various medicine components in each embodiment are the finished product Chinese crude drug buied from pharmacy or market, adopts the mode that is decocted in water for oral dose of traditional Chinese medicine composition medicament to take.Also said components can be ground to form by the fine powder that mesh is 0.4 screen cloth, and by above-mentioned fine powder 500g, starch 50g and distilled water 250g, mix homogeneously, make the pill of 0.14g mass with pellet processing machine.
Unit: g
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
Radix Angelicae Sinensis | 6 | 8 | 7 | 9 | 8 | 7 | 8 | 7 | 8 | 9 |
Rhizoma Chuanxiong | 6 | 8 | 7 | 9 | 8 | 7 | 8 | 7 | 8 | 9 |
Radix Salviae Miltiorrhizae | 7 | 8 | 9 | 7 | 9 | 8 | 9 | 7 | 8 | 10 |
Poria | 7 | 8 | 9 | 7 | 9 | 8 | 9 | 7 | 8 | 10 |
FRUCTUS SCHISANDRAE from Liaoning of China | 6 | 9 | 13 | 7 | 10 | 14 | 12 | 8 | 11 | 15 |
Cortex Magnoliae Officinalis | 7 | 8 | 9 | 7 | 9 | 8 | 9 | 8 | 7 | 10 |
Unit's meat | 6 | 8 | 7 | 9 | 8 | 7 | 8 | 7 | 8 | 9 |
The Rhizoma Pinelliae | 6 | 8 | 7 | 9 | 8 | 7 | 8 | 7 | 8 | 9 |
Fructus Perillae | 6 | 8 | 7 | 9 | 8 | 7 | 8 | 7 | 8 | 9 |
Radix Asteris | 7 | 9 | 8 | 7 | 8 | 9 | 7 | 8 | 7 | 9 |
Radix Panacis Quinquefolii | 6 | 7 | 8 | 7 | 8 | 6 | 8 | 7 | 6 | 9 |
Radix Ophiopogonis | 7 | 9 | 8 | 7 | 9 | 8 | 9 | 7 | 8 | 10 |
Rhizoma Corydalis | 6 | 6 | 7 | 8 | 7 | 6 | 8 | 6 | 7 | 8 |
Stigma Croci | 1 | 3 | 2 | 1 | 2 | 2 | 1 | 2 | 1 | 3 |
Pericarpium Citri Reticulatae | 6 | 7 | 6 | 7 | 7 | 7 | 6 | 7 | 6 | 7 |
Testis et penis callorhini | 6 | 8 | 9 | 7 | 8 | 9 | 6 | 8 | 7 | 9 |
Cordyceps | 1 | 2 | 3 | 1 | 2 | 3 | 2 | 1 | 2 | 3 |
Radix Bupleuri | 8 | 9 | 10 | 9 | 9 | 8 | 10 | 9 | 8 | 10 |
Radix Platycodonis | 8 | 9 | 10 | 9 | 9 | 8 | 10 | 9 | 8 | 10 |
The each component of the present invention can amplify in proportion, namely industrialization can be adopted in units of kilogram, ton to produce oral liquid (finished product decoction), its dose dose of a dose of medicine in grams in the present invention is standard unit (dose), according to the dose reducing finished product decoction after the ratiometric conversion after concentration.Also by above-mentioned fine powder, starch and distilled water, industrialization pellet processing machine can be adopted in units of kilogram, ton to make the pill of 0.14g mass.
Claims (3)
1. treat cardiopathic Chinese medicine for one kind, it is characterised in that it contains the Chinese crude drug of following component, and the composition of each component is all in units of weight: Radix Angelicae Sinensis 6~9g, Rhizoma Chuanxiong 6~9g, Radix Salviae Miltiorrhizae 7~10g, Poria 7~10g, FRUCTUS SCHISANDRAE from Liaoning of China 6~15g, Cortex Magnoliae Officinalis 7~10g, unit meat 6~9g, the Rhizoma Pinelliae 6~9g, Fructus Perillae 6~9g, Radix Asteris 7~9g, Radix Panacis Quinquefolii 6~9g, Radix Ophiopogonis 7~10g, Rhizoma Corydalis 6~8g, Stigma Croci 1~3g, Pericarpium Citri Reticulatae 6~9g, Testis et penis callorhini 6~9g, Cordyceps 1~3g, Radix Bupleuri 8~10, Radix Platycodonis 8~10.
2. one according to claim 1 treats cardiopathic Chinese medicine, it is characterised in that the content of each component is: Radix Angelicae Sinensis 7~8g, Rhizoma Chuanxiong 7~8g, Radix Salviae Miltiorrhizae 8~9g, Poria 8~9g, FRUCTUS SCHISANDRAE from Liaoning of China 8~12g, Cortex Magnoliae Officinalis 8~9g, unit meat 7~8g, the Rhizoma Pinelliae 7~8g, Fructus Perillae 7~8g, Radix Asteris 7~8g, Radix Panacis Quinquefolii 7~8g, Radix Ophiopogonis 8~9g, Rhizoma Corydalis 7g, Stigma Croci 2g, Pericarpium Citri Reticulatae 7~8g, Testis et penis callorhini 7~8g, Cordyceps 2g, Radix Bupleuri 9, Radix Platycodonis 9.
3. one according to claim 1 treats cardiopathic Chinese medicine, it is characterised in that the content of each component is: Radix Angelicae Sinensis 8g, Rhizoma Chuanxiong 8g, Radix Salviae Miltiorrhizae 9g, Poria 9g, FRUCTUS SCHISANDRAE from Liaoning of China 10g, Cortex Magnoliae Officinalis 9g, unit meat 8g, Rhizoma Pinelliae 8g, Fructus Perillae 8g, Radix Asteris 8g, Radix Panacis Quinquefolii 8g, Radix Ophiopogonis 9g, Rhizoma Corydalis 7g, Stigma Croci 2g, Pericarpium Citri Reticulatae 8g, Testis et penis callorhini 8g, Cordyceps 2g, Radix Bupleuri 9, Radix Platycodonis 9.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610350529.5A CN105770404A (en) | 2016-05-25 | 2016-05-25 | Traditional Chinese medicine for treating heart disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610350529.5A CN105770404A (en) | 2016-05-25 | 2016-05-25 | Traditional Chinese medicine for treating heart disease |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105770404A true CN105770404A (en) | 2016-07-20 |
Family
ID=56380340
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610350529.5A Pending CN105770404A (en) | 2016-05-25 | 2016-05-25 | Traditional Chinese medicine for treating heart disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105770404A (en) |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634471A (en) * | 2004-11-18 | 2005-07-06 | 李克武 | Chinese traditional medicine for treating cardiopathy |
CN101011522A (en) * | 2007-02-12 | 2007-08-08 | 王保德 | Chinese traditional medicine for treating cardiopathy |
CN102861220A (en) * | 2011-07-06 | 2013-01-09 | 天津太平洋制药有限公司 | Traditional Chinese medicine for treating heart disease |
CN103520589A (en) * | 2013-10-11 | 2014-01-22 | 陈国军 | Medicament used for treating heart diseases |
CN104107321A (en) * | 2013-04-19 | 2014-10-22 | 辛舒畅 | Traditional Chinese medicine composition for treating coronary heart disease |
CN104547406A (en) * | 2013-10-16 | 2015-04-29 | 耿文杰 | Traditional Chinese medicine for treating heart disease |
-
2016
- 2016-05-25 CN CN201610350529.5A patent/CN105770404A/en active Pending
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1634471A (en) * | 2004-11-18 | 2005-07-06 | 李克武 | Chinese traditional medicine for treating cardiopathy |
CN101011522A (en) * | 2007-02-12 | 2007-08-08 | 王保德 | Chinese traditional medicine for treating cardiopathy |
CN102861220A (en) * | 2011-07-06 | 2013-01-09 | 天津太平洋制药有限公司 | Traditional Chinese medicine for treating heart disease |
CN104107321A (en) * | 2013-04-19 | 2014-10-22 | 辛舒畅 | Traditional Chinese medicine composition for treating coronary heart disease |
CN103520589A (en) * | 2013-10-11 | 2014-01-22 | 陈国军 | Medicament used for treating heart diseases |
CN104547406A (en) * | 2013-10-16 | 2015-04-29 | 耿文杰 | Traditional Chinese medicine for treating heart disease |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103071128B (en) | Externally-applied plaster for curing dysmenorrhea | |
CN103301426A (en) | Capsule for invigorating circulation and benefiting heart | |
CN103041336B (en) | Traditional Chinese medicine composition for treating coronary heart disease | |
CN102114231B (en) | Medicine for treating arrhythmia | |
CN104258350A (en) | Traditional Chinese medicine preparation for treating sick sinus syndrome and preparation method of traditional Chinese medicine preparation | |
CN103071120B (en) | Medicine for treating silicosis | |
CN102406834A (en) | Medicament for treating Yang deficiency of women menopause syndrome | |
CN103919910A (en) | Medicine for treating coronary heart disease | |
CN103285343B (en) | Medicine for treating liver cancer and preparation method thereof | |
CN105381420A (en) | Traditional Chinese medicine for treating fatty liver | |
CN104606561A (en) | Traditional Chinese medicinal composition for treating spontaneous perspiration | |
CN104606514A (en) | Traditional Chinese medicine composition for treating kidney deficiency type tinnitus | |
CN101496892A (en) | Oral Chinese patent medicine for treating cardiovascular disease | |
CN103550674A (en) | Blood stasis removing and blood circulation invigorating soup | |
CN103169855A (en) | Drug composition for treating chronic heart failure | |
CN105963450A (en) | Traditional Chinese medicine composition for treating dizziness and faintness | |
CN103028076B (en) | Traditional Chinese medicine composition for treating liver cirrhosis | |
CN105456924A (en) | Traditional Chinese medicine preparation containing Folium Artemisiae Argyi and having functions of promoting circulation and removing stasis and preparation method thereof | |
CN105477330A (en) | Traditional Chinese medicine composition for treating arrhythmia | |
CN1149095C (en) | Chinese medicine for treating baby's congenital heart disease | |
CN104548012A (en) | Traditional Chinese medicine composition for treating amyloid cardiomyopathy | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN101983712A (en) | Novel medicament for treating coronary heart disease | |
CN105770404A (en) | Traditional Chinese medicine for treating heart disease | |
CN104042839A (en) | Traditional Chinese medicine composition for treating tinea versicolor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160720 |